Vespa velutina chromosome 19, iVesVel2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU525141.1.\nAssembly name: iVesVel2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/08/14. The original whole-genome shotgun project has the\naccession CAJVVP000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa velutina Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X1
guanine nucleotide-binding protein subunit alpha homolog
formin-like protein, transcript variant X2
formin-like protein, transcript variant X1
formin-like protein, transcript variant X3
formin-like protein, transcript variant X4
ADP-ribosylation factor-like protein 4C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ADP-ribosylation factor-like protein 4C, transcript variant X1
ADP-ribosylation factor-like protein 4C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ADP-ribosylation factor-like protein 4C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ADP-ribosylation factor-like protein 4C, transcript variant X3
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X3
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X1
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X4
28 kDa heat- and acid-stable phosphoprotein-like, transcript variant X2
28 kDa heat- and acid-stable phosphoprotein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial, transcript variant X2
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial, transcript variant X1
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial, transcript variant X3
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial, transcript variant X4
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial isoform X1
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial isoform X2
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial isoform X3
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X4
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X6
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X5
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 25-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 25-like isoform X2
mediator of RNA polymerase II transcription subunit 25-like isoform X4
mediator of RNA polymerase II transcription subunit 25-like isoform X3
mediator of RNA polymerase II transcription subunit 25-like isoform X1
spermatogenesis-defective protein 39 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
spermatogenesis-defective protein 39 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC124955931 isoform X2
spermatogenesis-defective protein 39 homolog isoform X1
RNA polymerase II subunit A C-terminal domain phosphatase, transcript variant X1
RNA polymerase II subunit A C-terminal domain phosphatase, transcript variant X2
RNA polymerase II subunit A C-terminal domain phosphatase isoform X1
RNA polymerase II subunit A C-terminal domain phosphatase, transcript variant X3
RNA polymerase II subunit A C-terminal domain phosphatase isoform X2
28S ribosomal protein S17, mitochondrial
probable glutamate receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable glutamate receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable glutamate receptor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable glutamate receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124955891, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124955891, transcript variant X1
uncharacterized protein LOC124955891 isoform X1
uncharacterized protein LOC124955891 isoform X2
cilia- and flagella-associated protein 43-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 43-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cilia- and flagella-associated protein 43-like isoform X1
cilia- and flagella-associated protein 43-like isoform X2
uncharacterized LOC124955897, transcript variant X1
uncharacterized LOC124955897, transcript variant X2
uncharacterized protein LOC124955897 isoform X1
uncharacterized protein LOC124955897 isoform X2
carboxypeptidase N subunit 2-like, transcript variant X1
carboxypeptidase N subunit 2-like, transcript variant X3
carboxypeptidase N subunit 2-like, transcript variant X2
carboxypeptidase N subunit 2-like, transcript variant X4
carboxypeptidase N subunit 2-like isoform X1
carboxypeptidase N subunit 2-like isoform X3
carboxypeptidase N subunit 2-like isoform X2
uncharacterized LOC124955898, transcript variant X2
uncharacterized LOC124955898, transcript variant X4
uncharacterized LOC124955898, transcript variant X3
uncharacterized LOC124955898, transcript variant X1
uncharacterized LOC124955898, transcript variant X11
uncharacterized LOC124955898, transcript variant X10
uncharacterized protein LOC124955898 isoform X1
uncharacterized protein LOC124955898 isoform X3
uncharacterized LOC124955898, transcript variant X12
uncharacterized protein LOC124955898 isoform X4
uncharacterized protein LOC124955898 isoform X5
uncharacterized LOC124955898, transcript variant X9
uncharacterized LOC124955898, transcript variant X6
uncharacterized LOC124955898, transcript variant X7
uncharacterized LOC124955898, transcript variant X5
uncharacterized LOC124955898, transcript variant X8
uncharacterized protein LOC124955898 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cysteine and histidine-rich protein 1 homolog
calcium-independent phospholipase A2-gamma-like, transcript variant X4
calcium-independent phospholipase A2-gamma-like, transcript variant X1
calcium-independent phospholipase A2-gamma-like, transcript variant X3
calcium-independent phospholipase A2-gamma-like isoform X1
calcium-independent phospholipase A2-gamma-like isoform X3
calcium-independent phospholipase A2-gamma-like, transcript variant X2
calcium-independent phospholipase A2-gamma-like, transcript variant X5
calcium-independent phospholipase A2-gamma-like isoform X2
calcium-independent phospholipase A2-gamma-like isoform X4
atrial natriuretic peptide receptor 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: atrial natriuretic peptide receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124955903, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124955903, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124955903, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC124955903 isoform X1
uncharacterized protein LOC124955903 isoform X2
cysteine sulfinic acid decarboxylase, transcript variant X1
cysteine sulfinic acid decarboxylase, transcript variant X4
cysteine sulfinic acid decarboxylase, transcript variant X3
cysteine sulfinic acid decarboxylase, transcript variant X2
cysteine sulfinic acid decarboxylase isoform X1
cysteine sulfinic acid decarboxylase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
thyrotropin-releasing hormone receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
thyrotropin-releasing hormone receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
thyrotropin-releasing hormone receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
growth hormone secretagogue receptor type 1 isoform X1
thyrotropin-releasing hormone receptor isoform X2
growth hormone secretagogue receptor type 1 isoform X3
uncharacterized LOC124955806, transcript variant X1
uncharacterized LOC124955806, transcript variant X2
uncharacterized LOC124955806, transcript variant X3
uncharacterized protein LOC124955806 isoform X1
uncharacterized protein LOC124955806 isoform X2
uncharacterized protein LOC124955806 isoform X3
uncharacterized LOC124955815, transcript variant X1
regulator of G-protein signaling loco, transcript variant X3
regulator of G-protein signaling loco, transcript variant X1
regulator of G-protein signaling loco, transcript variant X2
regulator of G-protein signaling loco isoform X1
regulator of G-protein signaling loco isoform X2
regulator of G-protein signaling loco isoform X3
uncharacterized LOC124955815, transcript variant X2
M-phase inducer phosphatase-like, transcript variant X1
M-phase inducer phosphatase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
M-phase inducer phosphatase-like, transcript variant X4
M-phase inducer phosphatase-like, transcript variant X3
M-phase inducer phosphatase-like isoform X1
uncharacterized LOC124955816, transcript variant X3
uncharacterized LOC124955816, transcript variant X1
uncharacterized LOC124955816, transcript variant X2
M-phase inducer phosphatase-like, transcript variant X5
M-phase inducer phosphatase-like isoform X2
M-phase inducer phosphatase-like, transcript variant X6
M-phase inducer phosphatase-like, transcript variant X7
M-phase inducer phosphatase-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
guanine nucleotide exchange factor DBS-like, transcript variant X3
guanine nucleotide exchange factor DBS-like, transcript variant X1
guanine nucleotide exchange factor DBS-like, transcript variant X2
guanine nucleotide exchange factor DBS-like, transcript variant X4
guanine nucleotide exchange factor DBS-like, transcript variant X5
guanine nucleotide exchange factor DBS-like isoform X1
guanine nucleotide exchange factor DBS-like isoform X2
guanine nucleotide exchange factor DBS-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable serine/threonine-protein kinase kinX, transcript variant X3
probable serine/threonine-protein kinase kinX, transcript variant X2
probable serine/threonine-protein kinase kinX, transcript variant X7
probable serine/threonine-protein kinase kinX, transcript variant X6
probable serine/threonine-protein kinase kinX, transcript variant X1
probable serine/threonine-protein kinase kinX, transcript variant X4
probable serine/threonine-protein kinase kinX, transcript variant X5
uncharacterized protein DDB_G0284459 isoform X3
probable serine/threonine-protein kinase kinX isoform X1
microtubule-associated protein futsch isoform X4
probable serine/threonine-protein kinase kinX isoform X2
transcription elongation factor SPT5-like
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X1
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X2
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X3
tyrosine-protein kinase transmembrane receptor Ror isoform X1
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X4
tyrosine-protein kinase transmembrane receptor Ror isoform X3
uncharacterized LOC124955771, transcript variant X4
uncharacterized LOC124955771, transcript variant X2
uncharacterized LOC124955771, transcript variant X3
uncharacterized LOC124955771, transcript variant X1
uncharacterized LOC124955771, transcript variant X8
uncharacterized LOC124955771, transcript variant X5
uncharacterized LOC124955771, transcript variant X6
uncharacterized LOC124955771, transcript variant X7
uncharacterized protein LOC124955771 isoform X1
uncharacterized protein LOC124955771 isoform X2
uncharacterized protein LOC124955771 isoform X3
tyrosine-protein kinase transmembrane receptor Ror isoform X2
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X7
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X6
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X5
tyrosine-protein kinase transmembrane receptor Ror isoform X4
tyrosine-protein kinase transmembrane receptor Ror, transcript variant X8
tyrosine-protein kinase transmembrane receptor Ror isoform X5
glutamate receptor ionotropic, kainate glr-3-like, transcript variant X1
glutamate receptor ionotropic, kainate glr-3-like, transcript variant X2
glutamate receptor ionotropic, kainate glr-3-like isoform X1
glutamate receptor ionotropic, kainate glr-3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124955698, transcript variant X1
uncharacterized LOC124955698, transcript variant X5
uncharacterized LOC124955698, transcript variant X2
uncharacterized LOC124955698, transcript variant X4
uncharacterized LOC124955698, transcript variant X6
uncharacterized LOC124955698, transcript variant X3
uncharacterized protein LOC124955698 isoform X2
uncharacterized protein LOC124955698 isoform X1
E3 ubiquitin-protein ligase RMND5A, transcript variant X2
E3 ubiquitin-protein ligase RMND5A, transcript variant X1
E3 ubiquitin-protein ligase RMND5A isoform X1
E3 ubiquitin-protein ligase RMND5A isoform X2
uncharacterized LOC124955687, transcript variant X4
uncharacterized LOC124955687, transcript variant X2
uncharacterized LOC124955687, transcript variant X6
uncharacterized LOC124955687, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124955687, transcript variant X3
uncharacterized LOC124955687, transcript variant X1
uncharacterized protein LOC124955687 isoform X1
uncharacterized protein LOC124955687 isoform X2
synaptic vesicular amine transporter, transcript variant X1
synaptic vesicular amine transporter, transcript variant X3
synaptic vesicular amine transporter, transcript variant X2
synaptic vesicular amine transporter, transcript variant X4
synaptic vesicular amine transporter, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X5
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X7
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X9
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X3
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X6
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X4
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X8
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X1
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X10
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X1
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X5
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X2
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase, transcript variant X11
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X3
alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc transporter 2-like, transcript variant X2
zinc transporter 2-like, transcript variant X4
zinc transporter 2-like, transcript variant X1
zinc transporter 2-like, transcript variant X3
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X3
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X1
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X4
UDP-glucose:glycoprotein glucosyltransferase, transcript variant X2
UDP-glucose:glycoprotein glucosyltransferase isoform X3
UDP-glucose:glycoprotein glucosyltransferase isoform X1
UDP-glucose:glycoprotein glucosyltransferase isoform X4
UDP-glucose:glycoprotein glucosyltransferase isoform X2
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X5
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X4
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 15-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 15-like
general odorant-binding protein 83a-like, transcript variant X5
general odorant-binding protein 83a-like, transcript variant X4
general odorant-binding protein 83a-like, transcript variant X1
general odorant-binding protein 83a-like, transcript variant X2
general odorant-binding protein 83a-like, transcript variant X3
general odorant-binding protein 83a-like isoform X1
general odorant-binding protein 69a-like isoform X2
general odorant-binding protein 83a-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
CXXC motif containing zinc binding protein
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124955764, transcript variant X3
uncharacterized LOC124955764, transcript variant X2
uncharacterized LOC124955764, transcript variant X1
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC124955765, transcript variant X2
uncharacterized LOC124955765, transcript variant X1
ribosomal RNA processing protein 36 homolog
sodium/potassium-transporting ATPase subunit alpha, transcript variant X6
sodium/potassium-transporting ATPase subunit alpha, transcript variant X4
sodium/potassium-transporting ATPase subunit alpha, transcript variant X3
sodium/potassium-transporting ATPase subunit alpha, transcript variant X1
sodium/potassium-transporting ATPase subunit alpha, transcript variant X5
sodium/potassium-transporting ATPase subunit alpha, transcript variant X2
sodium/potassium-transporting ATPase subunit alpha isoform X6
sodium/potassium-transporting ATPase subunit alpha isoform X4
sodium/potassium-transporting ATPase subunit alpha isoform X3
sodium/potassium-transporting ATPase subunit alpha isoform X1
sodium/potassium-transporting ATPase subunit alpha isoform X5
sodium/potassium-transporting ATPase subunit alpha isoform X2
sodium/potassium-transporting ATPase subunit alpha, transcript variant X9
sodium/potassium-transporting ATPase subunit alpha, transcript variant X7
sodium/potassium-transporting ATPase subunit alpha, transcript variant X8
sodium/potassium-transporting ATPase subunit alpha, transcript variant X11
sodium/potassium-transporting ATPase subunit alpha, transcript variant X12
sodium/potassium-transporting ATPase subunit alpha, transcript variant X10
sodium/potassium-transporting ATPase subunit alpha, transcript variant X13
sodium/potassium-transporting ATPase subunit alpha, transcript variant X14
sodium/potassium-transporting ATPase subunit alpha, transcript variant X15
sodium/potassium-transporting ATPase subunit alpha isoform X7
sodium/potassium-transporting ATPase subunit alpha, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit alpha isoform X8
NPC intracellular cholesterol transporter 2-like
39S ribosomal protein S18a, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ribosome-releasing factor 2, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ribosome-releasing factor 2, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ribosome-releasing factor 2, mitochondrial, transcript variant X2
ribosome-releasing factor 2, mitochondrial isoform X1
ribosome-releasing factor 2, mitochondrial isoform X2
ribosomal protein VAR1, mitochondrial-like
transcription factor kayak, transcript variant X3
transcription factor kayak, transcript variant X1
transcription factor kayak, transcript variant X2
transcription factor kayak, transcript variant X4
transcription factor kayak, transcript variant X7
transcription factor kayak, transcript variant X5
transcription factor kayak, transcript variant X6
p53 and DNA damage-regulated protein 1, transcript variant X1
p53 and DNA damage-regulated protein 1, transcript variant X3
p53 and DNA damage-regulated protein 1, transcript variant X2
p53 and DNA damage-regulated protein 1 isoform X1
p53 and DNA damage-regulated protein 1 isoform X2
hairy/enhancer-of-split related with YRPW motif protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ribosome biogenesis protein BMS1 homolog, transcript variant X1
ribosome biogenesis protein BMS1 homolog, transcript variant X3
ribosome biogenesis protein BMS1 homolog, transcript variant X2
ribosome biogenesis protein BMS1 homolog isoform X1
ribosome biogenesis protein BMS1 homolog isoform X3
ribosome biogenesis protein BMS1 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
octopamine receptor beta-2R, transcript variant X11
octopamine receptor beta-2R, transcript variant X10
octopamine receptor beta-2R, transcript variant X9
octopamine receptor beta-2R, transcript variant X2
octopamine receptor beta-2R, transcript variant X3
octopamine receptor beta-2R, transcript variant X1
octopamine receptor beta-2R, transcript variant X5
octopamine receptor beta-2R, transcript variant X4
octopamine receptor beta-2R, transcript variant X8
octopamine receptor beta-2R, transcript variant X6
octopamine receptor beta-2R, transcript variant X7
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X1
polypeptide N-acetylgalactosaminyltransferase 3-like, transcript variant X3
polypeptide N-acetylgalactosaminyltransferase 3-like isoform X2
polypeptide N-acetylgalactosaminyltransferase 3-like isoform X1
polypeptide N-acetylgalactosaminyltransferase 3-like isoform X3
Krueppel-like factor luna, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Krueppel-like factor luna, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Krueppel-like factor luna, transcript variant X2
Krueppel-like factor luna, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
histone-lysine N-methyltransferase PRDM16-like, transcript variant X3
histone-lysine N-methyltransferase PRDM16-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone-lysine N-methyltransferase PRDM16-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
histone-lysine N-methyltransferase PRDM16-like, transcript variant X4
histone-lysine N-methyltransferase PRDM16-like isoform X3
histone-lysine N-methyltransferase PRDM16-like isoform X2
histone-lysine N-methyltransferase PRDM16-like isoform X1
histone-lysine N-methyltransferase PRDM16-like isoform X4
uncharacterized LOC124955838, transcript variant X3
uncharacterized LOC124955838, transcript variant X1
uncharacterized LOC124955838, transcript variant X2
uncharacterized protein LOC124955836 isoform X1
uncharacterized protein LOC124955836 isoform X2
uncharacterized LOC124955639, transcript variant X2
uncharacterized LOC124955639, transcript variant X1
uncharacterized protein LOC124955639 isoform X2
uncharacterized protein LOC124955639 isoform X1
probable serine/threonine-protein kinase kinX
protein abrupt-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
protein abrupt-like, transcript variant X1
protein abrupt-like, transcript variant X2
transcriptional regulator Kaiso-like isoform X5
uncharacterized protein LOC124955677 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein abrupt-like, transcript variant X6
protein abrupt-like, transcript variant X3
protein abrupt-like, transcript variant X5
protein abrupt-like, transcript variant X4
protein tramtrack, beta isoform-like isoform X4
protein tramtrack, beta isoform-like isoform X2
uncharacterized LOC124955602, transcript variant X2
uncharacterized LOC124955602, transcript variant X3
uncharacterized LOC124955602, transcript variant X4
uncharacterized LOC124955602, transcript variant X1
uncharacterized protein LOC124955602 isoform X2
uncharacterized protein LOC124955602 isoform X1
uncharacterized LOC124955601, transcript variant X1
uncharacterized LOC124955601, transcript variant X4
uncharacterized protein LOC124955601 isoform X1
uncharacterized protein LOC124955601 isoform X4
uncharacterized LOC124955601, transcript variant X3
uncharacterized LOC124955601, transcript variant X5
uncharacterized LOC124955601, transcript variant X2
uncharacterized protein LOC124955601 isoform X2
uncharacterized protein LOC124955601 isoform X3
uncharacterized protein LOC124955601 isoform X5
uncharacterized LOC124955692, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124955692, transcript variant X1
laminin subunit alpha-1, transcript variant X1
laminin subunit alpha-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124955751, transcript variant X5
uncharacterized LOC124955751, transcript variant X3
uncharacterized LOC124955751, transcript variant X1
uncharacterized LOC124955751, transcript variant X4
uncharacterized LOC124955751, transcript variant X2
uncharacterized LOC124955753, transcript variant X2
uncharacterized LOC124955753, transcript variant X1
laminin subunit alpha-1, transcript variant X3
uncharacterized LOC124955752, transcript variant X6
uncharacterized LOC124955752, transcript variant X7
uncharacterized LOC124955752, transcript variant X2
uncharacterized LOC124955752, transcript variant X4
uncharacterized LOC124955752, transcript variant X5
uncharacterized LOC124955752, transcript variant X3
uncharacterized LOC124955752, transcript variant X1
laminin subunit alpha-1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
laminin subunit alpha-1, transcript variant X4
laminin subunit alpha-1, transcript variant X6
laminin subunit alpha-1, transcript variant X5
programmed cell death 6-interacting protein
small ubiquitin-related modifier-like, transcript variant X3
small ubiquitin-related modifier-like, transcript variant X1
small ubiquitin-related modifier-like, transcript variant X2
small ubiquitin-related modifier-like isoform X1
small ubiquitin-related modifier-like isoform X2
single-stranded DNA-binding protein, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
WD repeat-containing protein 75, transcript variant X1
WD repeat-containing protein 75 isoform X1
WD repeat-containing protein 75, transcript variant X2
WD repeat-containing protein 75 isoform X2
mediator of RNA polymerase II transcription subunit 1, transcript variant X1
mediator of RNA polymerase II transcription subunit 1 isoform X1
mediator of RNA polymerase II transcription subunit 1, transcript variant X2
mediator of RNA polymerase II transcription subunit 1 isoform X2
phosphoribosylformylglycinamidine synthase
alpha-N-acetylgalactosaminidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
alpha-N-acetylgalactosaminidase, transcript variant X2
alpha-N-acetylgalactosaminidase, transcript variant X4
alpha-N-acetylgalactosaminidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
BTB/POZ domain-containing protein 9, transcript variant X1
BTB/POZ domain-containing protein 9, transcript variant X3
BTB/POZ domain-containing protein 9, transcript variant X2
BTB/POZ domain-containing protein 9 isoform X1
BTB/POZ domain-containing protein 9 isoform X2
2',5'-phosphodiesterase 12, transcript variant X2
2',5'-phosphodiesterase 12, transcript variant X1
uncharacterized LOC124955636, transcript variant X3
uncharacterized LOC124955636, transcript variant X1
uncharacterized LOC124955636, transcript variant X2
uncharacterized LOC124955635, transcript variant X1
uncharacterized LOC124955635, transcript variant X3
uncharacterized LOC124955635, transcript variant X5
uncharacterized LOC124955635, transcript variant X2
uncharacterized LOC124955635, transcript variant X4
phospholipase B1, membrane-associated-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
S-adenosylmethionine synthase, transcript variant X2
S-adenosylmethionine synthase, transcript variant X1
S-adenosylmethionine synthase isoform X2
S-adenosylmethionine synthase isoform X1
alpha-protein kinase 1-like, transcript variant X1
alpha-protein kinase 1-like, transcript variant X6
alpha-protein kinase 1-like, transcript variant X3
alpha-protein kinase 1-like, transcript variant X2
alpha-protein kinase 1-like, transcript variant X5
putative uncharacterized protein DDB_G0294196 isoform X4
alpha-protein kinase 1-like, transcript variant X4
probable global transcription activator SNF2L2 isoform X3
probable E3 ubiquitin-protein ligase HERC4, transcript variant X2
probable E3 ubiquitin-protein ligase HERC4, transcript variant X4
probable E3 ubiquitin-protein ligase HERC4, transcript variant X1
probable E3 ubiquitin-protein ligase HERC4, transcript variant X7
probable E3 ubiquitin-protein ligase HERC4, transcript variant X3
probable E3 ubiquitin-protein ligase HERC4, transcript variant X8
probable E3 ubiquitin-protein ligase HERC4, transcript variant X6
probable E3 ubiquitin-protein ligase HERC4, transcript variant X5
probable E3 ubiquitin-protein ligase HERC4 isoform X2
probable E3 ubiquitin-protein ligase HERC4 isoform X3
probable E3 ubiquitin-protein ligase HERC4 isoform X5
probable E3 ubiquitin-protein ligase HERC4 isoform X1
probable E3 ubiquitin-protein ligase HERC4 isoform X4
probable E3 ubiquitin-protein ligase HERC4 isoform X6
probable E3 ubiquitin-protein ligase HERC4 isoform X7
moesin/ezrin/radixin homolog 1, transcript variant X7
moesin/ezrin/radixin homolog 1, transcript variant X8
moesin/ezrin/radixin homolog 1 isoform X7
moesin/ezrin/radixin homolog 1 isoform X8
moesin/ezrin/radixin homolog 1, transcript variant X2
moesin/ezrin/radixin homolog 1, transcript variant X3
moesin/ezrin/radixin homolog 1, transcript variant X4
moesin/ezrin/radixin homolog 1, transcript variant X5
moesin/ezrin/radixin homolog 1, transcript variant X6
moesin/ezrin/radixin homolog 1 isoform X2
moesin/ezrin/radixin homolog 1 isoform X3
moesin/ezrin/radixin homolog 1 isoform X4
moesin/ezrin/radixin homolog 1 isoform X5
moesin/ezrin/radixin homolog 1 isoform X6
moesin/ezrin/radixin homolog 1, transcript variant X9
moesin/ezrin/radixin homolog 1, transcript variant X1
moesin/ezrin/radixin homolog 1 isoform X9
moesin/ezrin/radixin homolog 1 isoform X1
mitogen-activated protein kinase kinase kinase 4, transcript variant X5
mitogen-activated protein kinase kinase kinase 4, transcript variant X7
mitogen-activated protein kinase kinase kinase 4, transcript variant X6
mitogen-activated protein kinase kinase kinase 4, transcript variant X2
mitogen-activated protein kinase kinase kinase 4, transcript variant X3
mitogen-activated protein kinase kinase kinase 4, transcript variant X1
mitogen-activated protein kinase kinase kinase 4, transcript variant X4
mitogen-activated protein kinase kinase kinase 4 isoform X1
mitogen-activated protein kinase kinase kinase 4 isoform X2
mitogen-activated protein kinase kinase kinase 4 isoform X4
mitogen-activated protein kinase kinase kinase 4 isoform X3
mitogen-activated protein kinase kinase kinase 4 isoform X6
mitogen-activated protein kinase kinase kinase 4 isoform X5
choline O-acetyltransferase, transcript variant X1
choline O-acetyltransferase, transcript variant X2
choline O-acetyltransferase, transcript variant X3
uncharacterized LOC124955835, transcript variant X3
uncharacterized LOC124955835, transcript variant X1
uncharacterized LOC124955835, transcript variant X2
uncharacterized LOC124955834, transcript variant X4
uncharacterized LOC124955834, transcript variant X1
uncharacterized LOC124955834, transcript variant X3
uncharacterized LOC124955834, transcript variant X2
high-affinity choline transporter 1, transcript variant X3
high-affinity choline transporter 1, transcript variant X2
high-affinity choline transporter 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
RNA-binding protein squid, transcript variant X1
RNA-binding protein squid, transcript variant X3
RNA-binding protein squid, transcript variant X2
RNA-binding protein squid, transcript variant X4
RNA-binding protein squid, transcript variant X6
RNA-binding protein squid, transcript variant X5
RNA-binding protein squid, transcript variant X7
RNA-binding protein squid, transcript variant X8
RNA-binding protein squid, transcript variant X9
ras GTPase-activating protein-binding protein 2, transcript variant X1
ras GTPase-activating protein-binding protein 2, transcript variant X2
ras GTPase-activating protein-binding protein 2, transcript variant X3
ras GTPase-activating protein-binding protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ribonuclease P protein subunit p21, transcript variant X8
ribonuclease P protein subunit p21, transcript variant X10
ribonuclease P protein subunit p21, transcript variant X7
ribonuclease P protein subunit p21, transcript variant X4
ribonuclease P protein subunit p21, transcript variant X2
ribonuclease P protein subunit p21, transcript variant X3
ribonuclease P protein subunit p21, transcript variant X1
ribonuclease P protein subunit p21, transcript variant X5
ribonuclease P protein subunit p21, transcript variant X6
ribonuclease P protein subunit p21, transcript variant X9
ribonuclease P protein subunit p21, transcript variant X11
TATA-binding protein-associated factor 172, transcript variant X1
TATA-binding protein-associated factor 172, transcript variant X2
TATA-binding protein-associated factor 172 isoform X1
TATA-binding protein-associated factor 172 isoform X2
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1-like
uncharacterized protein KIAA2013 homolog
metabotropic glutamate receptor 7-like, transcript variant X7
metabotropic glutamate receptor 7-like, transcript variant X6
metabotropic glutamate receptor 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
metabotropic glutamate receptor 7-like, transcript variant X3
metabotropic glutamate receptor 7-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
metabotropic glutamate receptor 7-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
metabotropic glutamate receptor 7-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
metabotropic glutamate receptor 7-like, transcript variant X10
metabotropic glutamate receptor 7-like, transcript variant X4
metabotropic glutamate receptor 7-like, transcript variant X5
metabotropic glutamate receptor 7-like, transcript variant X1
metabotropic glutamate receptor 7-like, transcript variant X8
metabotropic glutamate receptor 7-like isoform X2
metabotropic glutamate receptor 7-like isoform X3
metabotropic glutamate receptor 7-like isoform X1
metabotropic glutamate receptor 7-like isoform X4
dnaJ homolog subfamily C member 5, transcript variant X1
dnaJ homolog subfamily C member 5, transcript variant X2
dnaJ homolog subfamily C member 5, transcript variant X3
dnaJ homolog subfamily C member 5 isoform X1
dnaJ homolog subfamily C member 5 isoform X2
dnaJ homolog subfamily C member 5 isoform X3
uncharacterized LOC124955926, transcript variant X2
uncharacterized LOC124955926, transcript variant X5
uncharacterized LOC124955926, transcript variant X1
uncharacterized LOC124955926, transcript variant X3
uncharacterized LOC124955926, transcript variant X4
protein decapentaplegic-like, transcript variant X1
protein decapentaplegic-like, transcript variant X2
protein decapentaplegic-like, transcript variant X3
homeobox protein Nkx-2.2a-like, transcript variant X2
homeobox protein Nkx-2.2a-like isoform X2
homeobox protein Nkx-2.2a-like, transcript variant X1
homeobox protein Nkx-2.2a-like isoform X1
homeobox protein Nkx-2.2a-like, transcript variant X3
homeobox protein Nkx-2.2a-like isoform X3
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124955855, transcript variant X1
uncharacterized LOC124955855, transcript variant X3
uncharacterized LOC124955855, transcript variant X2
uncharacterized protein LOC124955855 isoform X2
uncharacterized protein LOC124955855 isoform X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X2
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 231 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X2
serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X1
alkylated DNA repair protein alkB homolog 8-like, transcript variant X4
alkylated DNA repair protein alkB homolog 8-like, transcript variant X2
alkylated DNA repair protein alkB homolog 8-like, transcript variant X1
alkylated DNA repair protein alkB homolog 8-like, transcript variant X3
alkylated DNA repair protein alkB homolog 8-like isoform X2
alkylated DNA repair protein alkB homolog 8-like, transcript variant X5
alkylated DNA repair protein alkB homolog 8-like isoform X1
alkylated DNA repair protein alkB homolog 8-like isoform X3
alkylated DNA repair protein alkB homolog 8-like isoform X4
serine-rich adhesin for platelets-like, transcript variant X3
serine-rich adhesin for platelets-like, transcript variant X7
serine-rich adhesin for platelets-like, transcript variant X9
serine-rich adhesin for platelets-like, transcript variant X8
serine-rich adhesin for platelets-like, transcript variant X5
serine-rich adhesin for platelets-like, transcript variant X6
serine-rich adhesin for platelets-like, transcript variant X1
serine-rich adhesin for platelets-like, transcript variant X10
serine-rich adhesin for platelets-like, transcript variant X2
serine-rich adhesin for platelets-like isoform X1
serine-rich adhesin for platelets-like isoform X3
serine-rich adhesin for platelets-like isoform X5
serine-rich adhesin for platelets-like isoform X6
serine-rich adhesin for platelets-like, transcript variant X4
serine-rich adhesin for platelets-like isoform X4
uncharacterized protein LOC124955935 isoform X7
ubiquitin carboxyl-terminal hydrolase 46, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 46, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 46, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 46, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 46 isoform X2
ubiquitin carboxyl-terminal hydrolase 46 isoform X1
WW domain-containing oxidoreductase-like, transcript variant X1
WW domain-containing oxidoreductase-like, transcript variant X2
WW domain-containing oxidoreductase-like
39S ribosomal protein L15, mitochondrial
CD109 antigen-like, transcript variant X2
CD109 antigen-like, transcript variant X1
CD109 antigen-like, transcript variant X3
apoptotic chromatin condensation inducer in the nucleus, transcript variant X2
apoptotic chromatin condensation inducer in the nucleus, transcript variant X1
apoptotic chromatin condensation inducer in the nucleus isoform X1
apoptotic chromatin condensation inducer in the nucleus isoform X2
transmembrane 9 superfamily member 2, transcript variant X1
transmembrane 9 superfamily member 2, transcript variant X2
transmembrane 9 superfamily member 2 isoform X2
transmembrane 9 superfamily member 2 isoform X1
transmembrane protein 231-like, transcript variant X2
transmembrane protein 231-like, transcript variant X1
transmembrane protein 231-like, transcript variant X3
transmembrane protein 231-like isoform X2
transmembrane protein 231-like isoform X1
transmembrane protein 231-like isoform X3
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X2
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2Q-like protein CG4502, transcript variant X3
ubiquitin-conjugating enzyme E2Q-like protein CG4502 isoform X1
ubiquitin-conjugating enzyme E2Q-like protein CG4502 isoform X2
Y+L amino acid transporter 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Y+L amino acid transporter 2, transcript variant X2
rab3 GTPase-activating protein catalytic subunit, transcript variant X1
rab3 GTPase-activating protein catalytic subunit, transcript variant X2
rab3 GTPase-activating protein catalytic subunit, transcript variant X3
rab3 GTPase-activating protein catalytic subunit, transcript variant X4
rab3 GTPase-activating protein catalytic subunit, transcript variant X5
rab3 GTPase-activating protein catalytic subunit, transcript variant X6
rab3 GTPase-activating protein catalytic subunit isoform X1
rab3 GTPase-activating protein catalytic subunit isoform X2
transport and Golgi organization protein 6 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
divergent protein kinase domain 2A-like, transcript variant X1
divergent protein kinase domain 2A-like, transcript variant X2
divergent protein kinase domain 2A-like isoform X1
divergent protein kinase domain 2A-like isoform X2
eukaryotic translation initiation factor 2-alpha kinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
eukaryotic translation initiation factor 2-alpha kinase 1-like, transcript variant X1
eukaryotic translation initiation factor 2-alpha kinase 1-like, transcript variant X3
eukaryotic translation initiation factor 2-alpha kinase 1-like isoform X2
eukaryotic translation initiation factor 2-alpha kinase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
2-oxoglutarate and iron-dependent oxygenase JMJD4, transcript variant X3
2-oxoglutarate and iron-dependent oxygenase JMJD4, transcript variant X1
H2.0-like homeobox protein, transcript variant X2
2-oxoglutarate and iron-dependent oxygenase JMJD4, transcript variant X2
2-oxoglutarate and iron-dependent oxygenase JMJD4 isoform X1
2-oxoglutarate and iron-dependent oxygenase JMJD4 isoform X2
H2.0-like homeobox protein, transcript variant X1
H2.0-like homeobox protein, transcript variant X3
uncharacterized LOC124955876, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124955878, transcript variant X3
uncharacterized LOC124955878, transcript variant X2
uncharacterized LOC124955878, transcript variant X1
uncharacterized LOC124955876, transcript variant X2
uncharacterized LOC124955876, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124955876, transcript variant X3
uncharacterized LOC124955876, transcript variant X6
uncharacterized LOC124955876, transcript variant X5
uncharacterized protein LOC124955876 isoform X4
uncharacterized protein LOC124955876 isoform X1
uncharacterized protein LOC124955876 isoform X3
uncharacterized protein LOC124955876 isoform X2
golgin subfamily A member 4, transcript variant X1
golgin subfamily A member 4, transcript variant X3
golgin subfamily A member 4, transcript variant X2
CAP-Gly domain-containing linker protein 1 isoform X3
centrosomal protein of 164 kDa isoform X2
centrosomal protein of 164 kDa isoform X1
golgin subfamily A member 4, transcript variant X5
golgin subfamily A member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
visual system homeobox 2-like, transcript variant X2
visual system homeobox 2-like, transcript variant X1
visual system homeobox 2-like, transcript variant X6
visual system homeobox 2-like, transcript variant X7
visual system homeobox 2-like, transcript variant X3
visual system homeobox 2-like, transcript variant X4
visual system homeobox 2-like, transcript variant X5
visual system homeobox 2-like isoform X1
visual system homeobox 2-like isoform X5
visual system homeobox 2-like isoform X2
visual system homeobox 2-like isoform X6
visual system homeobox 2-like isoform X3
visual system homeobox 2-like isoform X4
dopamine receptor 2, transcript variant X7
dopamine receptor 2, transcript variant X4
dopamine receptor 2, transcript variant X10
dopamine receptor 2, transcript variant X8
dopamine receptor 2, transcript variant X11
dopamine receptor 2, transcript variant X9
dopamine receptor 2, transcript variant X6
dopamine receptor 2, transcript variant X5
dopamine receptor 2, transcript variant X3
dopamine receptor 2, transcript variant X2
dopamine receptor 2, transcript variant X1
dopamine receptor 2, transcript variant X12
dopamine receptor 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dopamine receptor 2, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dopamine receptor 2, transcript variant X14
hemolymph lipopolysaccharide-binding protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
hemolymph lipopolysaccharide-binding protein-like, transcript variant X1
hemolymph lipopolysaccharide-binding protein-like isoform X2
hemolymph lipopolysaccharide-binding protein-like isoform X1
general odorant-binding protein 56d-like
double-stranded RNA-specific editase Adar, transcript variant X1
double-stranded RNA-specific editase Adar isoform X1
double-stranded RNA-specific editase Adar, transcript variant X3
double-stranded RNA-specific editase Adar, transcript variant X2
double-stranded RNA-specific editase Adar, transcript variant X4
double-stranded RNA-specific editase Adar isoform X2
major facilitator superfamily domain-containing protein 6, transcript variant X2
major facilitator superfamily domain-containing protein 6, transcript variant X1
major facilitator superfamily domain-containing protein 6 isoform X1
major facilitator superfamily domain-containing protein 6 isoform X2
gastrula zinc finger protein xFG20-1-like, transcript variant X3
gastrula zinc finger protein xFG20-1-like, transcript variant X2
gastrula zinc finger protein xFG20-1-like, transcript variant X1
gastrula zinc finger protein xFG20-1-like
uncharacterized LOC124955851, transcript variant X6
uncharacterized LOC124955851, transcript variant X5
uncharacterized LOC124955851, transcript variant X7
uncharacterized LOC124955851, transcript variant X1
uncharacterized LOC124955851, transcript variant X2
uncharacterized LOC124955851, transcript variant X3
uncharacterized LOC124955851, transcript variant X4
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X2
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X3
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X8
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X9
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X5
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X6
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X1
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X4
mushroom body large-type Kenyon cell-specific protein 1, transcript variant X7
mushroom body large-type Kenyon cell-specific protein 1 isoform X1
mushroom body large-type Kenyon cell-specific protein 1 isoform X2
mushroom body large-type Kenyon cell-specific protein 1 isoform X4
mushroom body large-type Kenyon cell-specific protein 1 isoform X3
RCC1 domain-containing protein 1, transcript variant X3
RCC1 domain-containing protein 1, transcript variant X2
RCC1 domain-containing protein 1, transcript variant X1
RCC1 domain-containing protein 1 isoform X1
RCC1 domain-containing protein 1 isoform X3
RCC1 domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124955609, transcript variant X2
uncharacterized LOC124955609, transcript variant X3
uncharacterized LOC124955609, transcript variant X1
uncharacterized protein LOC124955609 isoform X1
uncharacterized protein LOC124955609 isoform X2
uncharacterized protein LOC124955609 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
peroxisomal N(1)-acetyl-spermine/spermidine oxidase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
aromatic-L-amino-acid decarboxylase, transcript variant X2
aromatic-L-amino-acid decarboxylase, transcript variant X1
aromatic-L-amino-acid decarboxylase isoform X2
aromatic-L-amino-acid decarboxylase isoform X1
uncharacterized LOC124955871, transcript variant X2
uncharacterized LOC124955871, transcript variant X1
uncharacterized LOC124955871, transcript variant X3
uncharacterized protein LOC124955871 isoform X1
uncharacterized protein LOC124955871 isoform X2
collagen alpha-1(IV) chain, transcript variant X1
collagen alpha-1(IV) chain, transcript variant X2
nuclear receptor coactivator 2-like, transcript variant X15
nuclear receptor coactivator 2-like, transcript variant X12
nuclear receptor coactivator 2-like, transcript variant X14
nuclear receptor coactivator 2-like, transcript variant X5
nuclear receptor coactivator 2-like, transcript variant X6
nuclear receptor coactivator 2-like, transcript variant X2
nuclear receptor coactivator 2-like, transcript variant X8
nuclear receptor coactivator 2-like, transcript variant X4
nuclear receptor coactivator 2-like, transcript variant X7
nuclear receptor coactivator 2-like, transcript variant X11
nuclear receptor coactivator 2-like, transcript variant X1
nuclear receptor coactivator 2-like, transcript variant X3
nuclear receptor coactivator 2-like, transcript variant X13
nuclear receptor coactivator 2-like, transcript variant X10
nuclear receptor coactivator 2-like, transcript variant X9
nuclear receptor coactivator 2-like isoform X10
nuclear receptor coactivator 2-like isoform X2
nuclear receptor coactivator 1-like isoform X8
nuclear receptor coactivator 2-like isoform X3
nuclear receptor coactivator 2-like isoform X4
nuclear receptor coactivator 2-like isoform X7
nuclear receptor coactivator 2-like isoform X1
nuclear receptor coactivator 2-like isoform X5
nuclear receptor coactivator 2-like isoform X9
nuclear receptor coactivator 2-like isoform X6
ankyrin repeat domain-containing protein 39-like, transcript variant X4
ankyrin repeat domain-containing protein 39-like, transcript variant X2
ankyrin repeat domain-containing protein 39-like, transcript variant X3
uncharacterized protein LOC124955670 isoform X2
ankyrin repeat domain-containing protein 39-like, transcript variant X1
ankyrin repeat domain-containing protein 39-like isoform X1
tubulin alpha chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 357 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tubulin alpha chain-like, transcript variant X1
piggyBac transposable element-derived protein 4-like
probable small nuclear ribonucleoprotein G
uncharacterized LOC124955661, transcript variant X2
uncharacterized LOC124955661, transcript variant X1
uncharacterized LOC124955661, transcript variant X3
uncharacterized protein LOC124955661 isoform X1
uncharacterized protein LOC124955661 isoform X2
epsilon-sarcoglycan, transcript variant X2
epsilon-sarcoglycan, transcript variant X4
epsilon-sarcoglycan, transcript variant X1
epsilon-sarcoglycan, transcript variant X5
epsilon-sarcoglycan, transcript variant X3
vesicular integral-membrane protein VIP36
PPP2R1A-PPP2R2A-interacting phosphatase regulator 1
uncharacterized LOC124955673, transcript variant X2
uncharacterized LOC124955673, transcript variant X1
uncharacterized LOC124955673, transcript variant X3
adenomatous polyposis coli protein-like, transcript variant X1
adenomatous polyposis coli protein-like, transcript variant X2
adenomatous polyposis coli protein-like isoform X2
adenomatous polyposis coli protein-like isoform X1
zinc finger protein 423 homolog, transcript variant X2
zinc finger protein 423 homolog isoform X2
zinc finger protein 423 homolog, transcript variant X4
zinc finger protein 423 homolog, transcript variant X5
zinc finger protein 423 homolog, transcript variant X1
zinc finger protein 423 homolog isoform X1
zinc finger protein 423 homolog isoform X4
zinc finger protein 423 homolog, transcript variant X3
transcription factor IIIB 90 kDa subunit, transcript variant X4
transcription factor IIIB 90 kDa subunit, transcript variant X8
transcription factor IIIB 90 kDa subunit, transcript variant X1
transcription factor IIIB 90 kDa subunit, transcript variant X5
transcription factor IIIB 90 kDa subunit, transcript variant X3
transcription factor IIIB 90 kDa subunit, transcript variant X6
transcription factor IIIB 90 kDa subunit, transcript variant X7
transcription factor IIIB 90 kDa subunit, transcript variant X2
transcription factor IIIB 90 kDa subunit, transcript variant X9
transcription factor IIIB 90 kDa subunit
BTB/POZ domain-containing protein 6-B, transcript variant X2
BTB/POZ domain-containing protein 6-B, transcript variant X1
BTB/POZ domain-containing protein 6-B isoform X1
BTB/POZ domain-containing protein 6-B isoform X2
RNA-binding protein 4.1-like, transcript variant X7
RNA-binding protein 4.1-like, transcript variant X4
RNA-binding protein 4.1-like, transcript variant X2
RNA-binding protein 4.1-like, transcript variant X1
RNA-binding protein 4.1-like, transcript variant X8
RNA-binding protein 4.1-like, transcript variant X5
RNA-binding protein 4.1-like, transcript variant X6
RNA-binding protein 4.1-like, transcript variant X9
glycine-rich cell wall structural protein 1.8-like isoform X1
glycine-rich cell wall structural protein 1.8-like isoform X9
RNA-binding protein 4.1-like, transcript variant X3
glycine-rich cell wall structural protein 1.8-like isoform X3
RNA-binding protein 4.1-like, transcript variant X12
RNA-binding protein 4.1-like, transcript variant X11
RNA-binding protein 4.1-like, transcript variant X10
RNA-binding protein 4.1-like isoform X10
ubiquitin-like modifier-activating enzyme 5, transcript variant X1
ubiquitin-like modifier-activating enzyme 5, transcript variant X3
ubiquitin-like modifier-activating enzyme 5, transcript variant X2
ubiquitin-like modifier-activating enzyme 5 isoform X1
ubiquitin-like modifier-activating enzyme 5 isoform X2
uncharacterized LOC124955797, transcript variant X1
uncharacterized LOC124955797, transcript variant X5
uncharacterized LOC124955797, transcript variant X3
uncharacterized LOC124955797, transcript variant X4
uncharacterized LOC124955797, transcript variant X2
uncharacterized protein LOC124955797 isoform X1
uncharacterized protein LOC124955797 isoform X3
uncharacterized protein LOC124955797 isoform X2
nucleic acid dioxygenase ALKBH1, transcript variant X3
nucleic acid dioxygenase ALKBH1, transcript variant X1
nucleic acid dioxygenase ALKBH1, transcript variant X2
nucleic acid dioxygenase ALKBH1 isoform X3
nucleic acid dioxygenase ALKBH1 isoform X2
nucleic acid dioxygenase ALKBH1 isoform X1
activating transcription factor 3, transcript variant X5
activating transcription factor 3, transcript variant X4
activating transcription factor 3, transcript variant X1
activating transcription factor 3, transcript variant X3
activating transcription factor 3, transcript variant X2
protein transport protein Sec61 subunit gamma
NPC intracellular cholesterol transporter 2 homolog a-like
serine/threonine/tyrosine-interacting protein-like
endothelin-converting enzyme homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
endothelin-converting enzyme homolog, transcript variant X3
endothelin-converting enzyme homolog isoform X1
endothelin-converting enzyme homolog, transcript variant X2
endothelin-converting enzyme homolog, transcript variant X5
endothelin-converting enzyme homolog isoform X2
endothelin-converting enzyme homolog, transcript variant X4
endothelin-converting enzyme homolog, transcript variant X6
endothelin-converting enzyme homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124955617, transcript variant X2
uncharacterized LOC124955617, transcript variant X1
uncharacterized protein LOC124955617 isoform X1
uncharacterized protein LOC124955617 isoform X2
organic solute transporter alpha-like protein 3
probable serine/threonine-protein kinase dyrk2, transcript variant X2
probable serine/threonine-protein kinase dyrk2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable serine/threonine-protein kinase dyrk2, transcript variant X3
probable serine/threonine-protein kinase dyrk2 isoform X2
probable serine/threonine-protein kinase dyrk2 isoform X1
probable serine/threonine-protein kinase dyrk2 isoform X3
kinesin-like protein KIF6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
disheveled-associated activator of morphogenesis 1, transcript variant X7
disheveled-associated activator of morphogenesis 1, transcript variant X4
disheveled-associated activator of morphogenesis 1 isoform X4
disheveled-associated activator of morphogenesis 1, transcript variant X9
disheveled-associated activator of morphogenesis 1, transcript variant X2
disheveled-associated activator of morphogenesis 1 isoform X2
kinesin-like protein KIF6, transcript variant X3
disheveled-associated activator of morphogenesis 1, transcript variant X8
disheveled-associated activator of morphogenesis 1, transcript variant X5
disheveled-associated activator of morphogenesis 1, transcript variant X1
disheveled-associated activator of morphogenesis 1, transcript variant X3
disheveled-associated activator of morphogenesis 1, transcript variant X6
disheveled-associated activator of morphogenesis 1 isoform X5
disheveled-associated activator of morphogenesis 1 isoform X1
disheveled-associated activator of morphogenesis 1 isoform X3
kinesin-like protein KIF6, transcript variant X2
disheveled-associated activator of morphogenesis 1, transcript variant X10
disheveled-associated activator of morphogenesis 1 isoform X6
disheveled-associated activator of morphogenesis 1, transcript variant X11
disheveled-associated activator of morphogenesis 1 isoform X7
39S ribosomal protein L30, mitochondrial, transcript variant X2
39S ribosomal protein L30, mitochondrial, transcript variant X1
39S ribosomal protein L30, mitochondrial
uncharacterized LOC124955709, transcript variant X1
uncharacterized LOC124955709, transcript variant X2
uncharacterized LOC124955709, transcript variant X4
uncharacterized LOC124955709, transcript variant X3
uncharacterized protein LOC124955709 isoform X1
uncharacterized protein LOC124955709 isoform X2
uncharacterized protein LOC124955709 isoform X3
paired mesoderm homeobox protein 1-like, transcript variant X1
paired mesoderm homeobox protein 1-like, transcript variant X2
paired mesoderm homeobox protein 1-like isoform X1
retinal homeobox protein Rx2-like isoform X2
dual specificity protein phosphatase MPK-4
probable serine/threonine-protein kinase mps1, transcript variant X3
probable serine/threonine-protein kinase mps1, transcript variant X1
probable serine/threonine-protein kinase mps1, transcript variant X2
probable serine/threonine-protein kinase mps1, transcript variant X4
probable serine/threonine-protein kinase mps1
casein kinase II subunit beta, transcript variant X2
casein kinase II subunit beta, transcript variant X1
casein kinase II subunit beta, transcript variant X3
casein kinase II subunit beta isoform X2
casein kinase II subunit beta isoform X1
casein kinase II subunit beta isoform X3
probable low affinity copper uptake protein 2, transcript variant X3
uncharacterized protein LOC124955727 isoform X3
probable low affinity copper uptake protein 2, transcript variant X1
probable low affinity copper uptake protein 2, transcript variant X2
probable low affinity copper uptake protein 2 isoform X1
probable low affinity copper uptake protein 2 isoform X2
endoplasmic reticulum chaperone BiP, transcript variant X2
endoplasmic reticulum chaperone BiP isoform X2
endoplasmic reticulum chaperone BiP, transcript variant X1
endoplasmic reticulum chaperone BiP isoform X1
RNA-binding protein Ro60-like, transcript variant X1
RNA-binding protein Ro60-like, transcript variant X2
uncharacterized LOC124955730, transcript variant X1
uncharacterized LOC124955730, transcript variant X2
uncharacterized LOC124955730, transcript variant X4
uncharacterized LOC124955730, transcript variant X3
tetratricopeptide repeat protein 27, transcript variant X1
tetratricopeptide repeat protein 27 isoform X1
tetratricopeptide repeat protein 27, transcript variant X2
tetratricopeptide repeat protein 27, transcript variant X3
tetratricopeptide repeat protein 27 isoform X2
carbonic anhydrase-like, transcript variant X2
carbonic anhydrase-like, transcript variant X1
serine/threonine-protein kinase 11-interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase 11-interacting protein, transcript variant X1
serine/threonine-protein kinase 11-interacting protein
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X3
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X1
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X4
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X2
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X10
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X7
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X8
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X6
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X5
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X9
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X3
calcium-binding mitochondrial carrier protein SCaMC-2-A isoform X2
calcium-binding mitochondrial carrier protein SCaMC-2-A isoform X7
calcium-binding mitochondrial carrier protein SCaMC-2-A isoform X5
calcium-binding mitochondrial carrier protein SCaMC-2-A isoform X4
calcium-binding mitochondrial carrier protein SCaMC-2-A isoform X6
endoplasmic reticulum metallopeptidase 1-like, transcript variant X2
endoplasmic reticulum metallopeptidase 1-like, transcript variant X8
endoplasmic reticulum metallopeptidase 1-like, transcript variant X5
endoplasmic reticulum metallopeptidase 1-like, transcript variant X6
endoplasmic reticulum metallopeptidase 1-like, transcript variant X3
endoplasmic reticulum metallopeptidase 1-like, transcript variant X4
endoplasmic reticulum metallopeptidase 1-like, transcript variant X1
endoplasmic reticulum metallopeptidase 1-like, transcript variant X7
endoplasmic reticulum metallopeptidase 1-like isoform X2
endoplasmic reticulum metallopeptidase 1-like isoform X3
endoplasmic reticulum metallopeptidase 1-like isoform X1
endoplasmic reticulum metallopeptidase 1-like isoform X4
26S proteasome complex subunit SEM1, transcript variant X1
26S proteasome complex subunit SEM1, transcript variant X2
neurogenic differentiation factor 1-like
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1, transcript variant X1
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1, transcript variant X3
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1, transcript variant X2
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 isoform X1
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 isoform X2
E3 ubiquitin-protein ligase MIB2-like, transcript variant X1
E3 ubiquitin-protein ligase MIB2-like, transcript variant X2
E3 ubiquitin-protein ligase MIB2-like isoform X1
E3 ubiquitin-protein ligase MIB2-like, transcript variant X3
E3 ubiquitin-protein ligase MIB2-like isoform X2
solute carrier family 25 member 44, transcript variant X2
solute carrier family 25 member 44, transcript variant X3
solute carrier family 25 member 44, transcript variant X1
solute carrier family 25 member 44, transcript variant X5
solute carrier family 25 member 44, transcript variant X4
solute carrier family 25 member 44, transcript variant X6
tigger transposable element-derived protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins